Ki, nM | |||
---|---|---|---|
[125I]-7-OH-PIPAT | [3H]-Spiperone | KiLow/Ki High | |
Agonists | |||
Quinpirole | 9.5 ± 1.5 | 634 ± 151 | 67 |
Dopamine | 17 ± 1.0 | 576 ± 192 | 34 |
Partial agonists | |||
S(−)-PPP | 56 ± 4.5 | 1034 ± 231 | 18 |
Terguride | 0.16 ± 0.01 | 0.36 ± 0.04 | 2 |
Aripiprizole | 0.34 ± 0.02 | 0.70 ± 0.22 | 2 |
Antagonists | |||
Butaclamol | 0.43 ± 0.09 | 0.16 ± 0.01 | 0.4 |
Haloperidol | 0.30 ± 0.06 | 0.16 ± 0.02 | 0.5 |
Ki values were determined by the method ofCheng and Prusoff (1973) using IC50 values determined by competition for the binding of the agonist [125I]-7-OH-PIPAT or the antagonist [3H]spiperone to membranes prepared from CHO cells expressing human recombinant D2L receptors. Binding of [125I]-7-OH-PIPAT was performed under conditions favoring formation of the agonist-preferring G protein-coupled state of D2 receptors (Ki high), whereas binding of [3H]spiperone was performed under conditions promoting the noncoupled state of D2 receptors (Ki low). IC50 values were obtained by fitting data to a one-site competitive binding curve using GraphPad Prism version 3.0. Data are the mean ± S.E.M., n= 3 to 4 or the mean ± range, n = 2 experiments.